AMCR
Amcor plc
AMCR has a slight edge over NKE overall, supported by stronger fundamentals.
NKE
NIKE, Inc.
NKE has lower modeled downside risk, despite its lower overall score.
AMCR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Weak |
AMCR's revenue and profitability are currently healthy, and its cash flow is stable, but its balance sheet is weak.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
AMCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | $38.71 | -12% |
| Current | 19x | $43.80 | — |
| Fair | 21x | $49.43 | +13% |
| Expensive | 28x | $64.25 | +47% |
Historical ranges are pointers, not guarantees.
AMCR's PE is in its cheap range at 19x.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over AMCR in the historical PE scenario, which offers more potential upside but is not a forecast.
AMCR Forward outlook
There aren't enough analyst estimates for AMCR to show an outlook.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
AMCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $2.33 | +36% |
| Q2 2026 | $2.38 | +31% |
| Q1 2026 | $1.45 | -48% |
| Q4 2025 | $1.53 | -45% |
| Q3 2025 | $1.71 | -36% |
| Q2 2025 | $1.81 | -28% |
| Q1 2025 | $2.80 | +24% |
| Q4 2024 | $2.76 | +25% |
AMCR has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
AMCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $6.1B | +6.7% |
| Q2 2026 | $6.4B | +26% |
| Q1 2026 | $5.9B | +77% |
| Q4 2025 | $5.4B | +68% |
| Q3 2025 | $5.7B | +71% |
| Q2 2025 | $5.1B | +44% |
| Q1 2025 | $3.3B | -2.3% |
| Q4 2024 | $3.2B | -0.3% |
AMCR has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.4% | -0.6 points |
| Q2 2026 | 10% | +8.4 points |
| Q1 2026 | 7.8% | -1.6 points |
| Q4 2025 | 6.1% | -3.1 points |
| Q3 2025 | 8% | -1.3 points |
| Q2 2025 | 1.7% | -9.5 points |
| Q1 2025 | 9.4% | +0.4 points |
| Q4 2024 | 9.2% | +1.7 points |
AMCR's operating margin was 7.4% last quarter, down 0.6 points from the same quarter a year ago.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over AMCR on profitability, with a higher operating margin.
AMCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$828M | -$457M |
| Q2 2026 | $1.4B | +52% |
| Q1 2026 | -$42M | -$42M |
| Q4 2025 | $282M | -15% |
| Q3 2025 | -$371M | +$43M |
| Q2 2025 | $894M | +11% |
| Q1 2025 | $0 | -100% |
| Q4 2024 | $330M | +36% |
AMCR has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
AMCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +800K shares |
| 1 year | +0.3% | +1.6M shares |
| 3 years | +57% | +169M shares |
| 5 years | +49% | +153M shares |
| Available history | +44% | +142M shares |
AMCR has 465M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
AMCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.2x | High |
| Q2 2026 | 3.9x | Elevated |
| Q1 2026 | 5.2x | High |
| Q4 2025 | 5.9x | High |
| Q3 2025 | 6.7x | High |
| Q2 2025 | 7.7x | High |
| Q1 2025 | 3.6x | Elevated |
| Q4 2024 | 3.5x | Elevated |
AMCR's net debt is about 4.2 years of its operating earnings (EBITDA), down from 6.7 years a year ago.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE has the edge over AMCR on leverage, with a lower net debt burden relative to earnings.
AMCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.1 | Neutral |
| Stochastic | 53.5 | Neutral |
AMCR's weekly RSI is 50 (neutral) and its Stochastic is 54 (neutral).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
AMCR PE vs Consumer Cyclical Sector
| Metric | AMCR | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 18x | 4.1% above |
| PE % | 27 | 47 | 20 pts below |
AMCR is trading at 19x earnings, in line with the Consumer Cyclical sector's median of 18x.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE has the edge over AMCR on valuation relative to its sector.
AMCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.0 | 0.5% below |
| 20 week MA | $44.6 | 1.8% below |
| 50 week MA | $42.9 | 2% above |
| 100 week MA | $44.3 | 1.2% below |
| 200 week MA | $47.4 | 7.5% below |
AMCR's trend is mixed: it's above one of its five weekly moving averages, and 7.5% below its 200-week average.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
AMCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.8 | $58.2 | +6.3% |
| 2021 | $58.2 | $58.3 | +0.2% |
| 2022 | $58.3 | $60.3 | +3.4% |
| 2023 | $60.3 | $48.2 | -20% |
| 2024 | $48.2 | $47.2 | -2.1% |
| 2025 | $47.2 | $41.6 | -12% |
| 2026 YTD | $41.6 | $43.8 | +5.3% |
AMCR has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.